Dr. Sakir Humayun Gultekin Joins Sylvester and Department of Pathology
Sakir Humayun (“Hume”) Gultekin, M.D., has joined Sylvester Comprehensive Cancer Center and the Department of Pathology & Laboratory Medicine at the University of Miami Miller School of Medicine and UHealth. Gultekin will serve as Director of Clinical and Molecular Neuropathology for the University of Miami Brain Tumor Initiative, where he will support its comprehensive brain tumor program via clinical and basic science research. He will also serve as the department’s Director of Neuropathology.
Gultekin joins UM from Oregon Health and Science University (OHSU) in Portland, where he has served since 2004, most recently as associate professor in the Department of Pathology. Prior to that, he was an assistant professor of pathology at Mount Sinai Medical Center in New York City. While at OHSU, he also served as the medical director for the Neuromuscular Pathology Laboratory, and as program director of OHSU’s Pathology Residency Program.
Gultekin received his M.D. from the Hacettepe University in Ankara, Turkey. He first completed his training as a clinical neurologist in the Istanbul University Hospital Department of Neurology. He subsequently completed a two-year fellowship in neuropathology at the University of Massachusetts and Brigham & Women’s Hospitals. He completed his training in anatomic pathology at the Weill-Cornell University Medical Center, and an oncologic pathology fellowship at Memorial Sloan-Kettering Cancer Center. He is board-certified in both anatomic pathology and neuropathology.
His research interests are brain tumors, paraneoplastic diseases of the nervous system and tissue markers of myopathy. He has many peer-reviewed publications and has authored a variety of chapters in reference textbooks. Clinically, Gultekin will be responsible for the neuropathology services offered at Sylvester Comprehensive Cancer Center, UHealth, University of Miami Hospital, Jackson Memorial Hospital and Holtz Children’s Hospital. He plans to expand neuropathology services, including a robust nerve and muscle biopsy laboratory that is expected to serve as a national reference center.